He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and reasonably well-trained dog. Change), You are commenting using your Twitter account. See Peter Kolchinsky's compensation, career history, education, & memberships. Dr. Peter Kolchinsky Ph.D. serves as Independent Director of the Company. Peter Kolchinsky, Ph.D. Hedge Fund Net Worth $4.93B Peter Kolchinsky manages more assets than 43% of other Hedge Fund Managers Average Return +0.32% Since Last Filing Last 12 Months 3 Years (Annualized) Portfolio Breakdown by Sector Portfolio Breakdown 97.31% Healthcare 1.12% Services 0.78% Technology 0.51% Financial RA Capital Management Portfolio Activity Company Name The RA Capital Nexus Fund closed at just over $300 million, they said in a statement. Your email address will not be published. Franklin Resources Inc, Dr. Kolchinsky earned his Ph.D. in virology from Harvard University and earned his bachelors degree in Biology from Cornell University. Data from the new InnoLead/KPMG US Integrating digital therapeutics early in the asset development process will allow for gathering of clinical data to drive a clearer value proposition that maximizes the potential of both products In addition, they want, Coming from diverse backgrounds and interests, the foursome. Insider trading is most common in February, with the busiest year in 2023. He holds a BA from Cornell University and a PhD in Virology from Harvard University. Tweet With huge thanks to RA Capital's Alex Martinez-Forte and Jacqueline Rhuda for extensive data analysis. Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. Kolchinsky Peter Ownership Network Ownership Network List of Kolchinsky Peter Name Position Linked company No Data Ownership Network Relation of Kolchinsky Peter Kolchinsky Peter Mailing Address Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. January 3, 2023 Feb 10th, Ed. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. Peter Kolchinsky is 43, he's been the Independent Director of Wave Life Sciences since 2015. UCLA CTSI | Accelerating Discoveries Toward Better Health | Main Harvard Divinity School and began doctoral work in Buddhist studies at the University of California, Berkeley. In . He currently works with the State and Local Government Practice Group of the consulting firm Accenture. If you're already an Endpoints subscriber, enter your email below for a She has a Masters in theological studies from Harvard Divinity School and began doctoral work in Buddhist studies at the University of California, Berkeley. Health Care. The largest trade he's ever made was buying 6,337,135 units of Kala Pharmaceuticals Inc stock on 13 March 2020 worth over $49,999,995. The company hired hundreds of new employees and paid . out how to maintain the house themselves, from the roof to the, Anna and Keri hope their husbands dont electroc, can be found busily working at The Blue Horse Inn most weekends. we figured our friends and family would try to talk us out of it, said Anna. There are 15 older and 2 younger executives at Wave Life Sciences. S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula (Greenblatt) . America is rightfully outraged when patients cant afford the medicines they need. Our new neighbors have a vision for The Blue Horse Inn and have already started on renovations to make the house as vibrant from the outside as it is on the inside. https://t.co/y9IG2Z5txl" The most active traders at the company are Insider trading is most common in June, with the busiest year in 2022. the community will feel welcome. One hopeful voice is biotech investor Peter Kolchinsky, the founder of RA Capital Management. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. The foursome plans to open for guests in the late spring of 2010. Recently at Mineralys Therapeutics, Inc, Peter Kolchinsky has sold an estimated value of $0 worth. The drug industry stands accused of charging too much. He is active in both public and private investments in companies developing drugs, medical devices, diagnostics and research tools and serves as a board member for various public and privately-held . Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. This ground-breaking new book, The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines (January 20, 2020), by Peter Kolchinsky, PhD, examines the healthcare landscape through the lens of the biotech social contract with America - the implicit agreement between the biopharmaceutical industry and American society - including the government's role in inventing . Everyone has been so generous with us, sharing advice and stories. Shes currently earning her PhD in European History at Boston College. Alfredo Naj Domingos prostate cancer was spreading. In addition, they want to provide guests with ample opportunities to enjoy local arts, food, and activities and look forward to collaborating with local artists, craftsmen, and business owners to come up with interesting packages. Peter Kolchinsky usually trades in September, with the busiest year in 2020. In total, Peter Kolchinsky has made about 5 transactions over a year of their time at Solid Biosciences Inc. Endpoints News connected with the new chair of the generic industrys Association for Accessible Medicines, Christine Baeder, who is also Tevas COO, via video conference on Friday. So they invited their close friends Keri and Ben up for what they expected to be a reality check. May 27, 2022 (This is a long piece; click here to read it in Bionic Reading format, which may for some increase reading speed and comprehension. But many people worry that Covid-19 will mutate and . . var _Hasync=_Hasync||[];_Hasync.push(['Histats.start','1,4553220,4,511,95,18,00000000']);_Hasync.push(['Histats.fasi','1']);_Hasync.push(['Histats.track_hits','']);(function(){var hs=document.createElement('script');hs.type='text/javascript';hs.async=true;hs.src=('//s10.histats.com/js15_as.js');(document.getElementsByTagName('head')[0]||document.getElementsByTagName('body')[0]).appendChild(hs);})(); Peter Kolchinsky is a famous person who is known worldwide for his work. Ignoring warning calls from pharma companies and the Association of the British Pharmaceutical Industry (ABPI), the UK government announced its planning to raise the revenue clawback rate paid by pharmaceutical companies on the Statutory Scheme for Branded Medicines from 24.4% to 27.5%. As for their long-term goals, Peter and Ben are determined to figure out how to maintain the house themselves, from the roof to the plumbing, by the time they retire. Peter Kolchinsky usually trades in December, with the busiest year in 2022. and bought an estimated value of $190.71M worth of shares. October 20, 2021The vaccine business has long been a quiet and profitable game of kings. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. But there was a lot of adjusting to do, for everyone in the family. Enjoy a 7-Day Free Trial Thru Mar 12, 2023! The Statutory Scheme, which is governed under UK law, is one of two that companies can use. Want this in your inbox every Saturday morning? These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of. Verified account Protected Tweets @; Suggested users Wallmine is a radically better financial terminal. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. It was written by our very kind neighbor, Hasse K. Halley. March 31, 2020. $20M on February 16, 2023. (LogOut/ They fell in love with the historic character and natural beauty of the area and, as they met more of the towns residents, realized that Woodstock was a community that they would like to be part of. They know that 3 Church Street is part of Woodstocks history and hope to create a place where not only guests but also the community will feel welcome. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. This investment adviser does not provide advice to individual investors. $5M . Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $46,860,585 and over the last 8 years he sold WVE stock worth over $58,095,632. NEW ORLEANS Esperion Therapeutics revealed long-awaited data on its heart pills efficacy in cutting severe cardiovascular outcomes, three years after the drug was cleared for use to lower cholesterol levels. The Great American Drug Deal was released on January 20, 2020. His wife, Nora Flor, said she and her sister made calls to at least 30 centers across the US looking for the drug. Currently, Peter is married. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Peter Kolchinsky started RA Capital Management after completing his Ph.D. in virology from Harvard in 2001. Most importantly, this book describes concrete, actionable reforms under which patients will be able to afford their treatments and society will continue to reap the benefits of medical innovation. Hbm Healthcare Investments Cayman Ltd who bought 3,218,106 units worth Keri is also a writer and is currently working on a Southern gothic novel. Both Moffitt Cancer Center and Mayo Clinic in Florida, not too far from Domingos and his family, said he would have to wait between three and a half and four months to get the treatment. As the Independent Director of Wave Life Sciences, the total compensation of Peter Kolchinsky at Wave Life Sciences is $151,598. Fundamental company data provided by Morningstar, updated daily. Peter Kolchinsky The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines Paperback - Illustrated, January 17, 2020 by Peter Kolchinsky (Author) 180 ratings See all formats and editions Kindle $9.99 Read with Our Free App Audiobook $0.00 Free with your Audible trial Paperback $140.3K . Peter Kolchinsky usually trades in February, with the busiest year in 2023. . Wave Life Sciences executives and other stock owners filed with the SEC include: Probieren Sie wallmine & ndash; es ist kostenlos. Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High . The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Peter Kolchinsky is Chairman/CEO at Research Alliance Corp II. Peter's reported annual income is about $100 - 149,999; with a net worth that tops $50,000 - $99,999. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. The current estimated net worth of Dyne Therapeutics, Inc's Peter Kolchinsky is estimated to be about $2.88B . Social image: Peter Kolchinsky and Raj Shah, RA Capital Management, Digital therapeutics support increased access to safe and effective therapies, providing an untapped opportunity for biopharmaceutical companies to maximize the value of medicinal assets and drive differentiation These things have helped him get to where he is now one of the richest people on Earth. Welcome to the official Blue Horse Inn blog! Early market entry is fundamental, and manufacturers must plan strategically to consider how digital therapeutics (DTx) are best incorporated into the launch and go-to-market strategy. GuruFocus.com is not operated by a broker or a dealer. 2004-2023 GuruFocus.com, LLC. She received her bachelors degree from Furman University in South Carolina in Philosophy and Asian Studies. . The estimated Net Worth of Peter Kolchinsky is at least $96.3 Million dollars as of 23 June 2020. For a patient who can't afford a $5,000 deductible, even slashing a $50,000 treatment's price by 90% would still leave that patient unable to afford his or her $5,000 out-of-pocket obligation. We loved the idea of having a second home that was also an inn, but we figured our friends and family would try to talk us out of it, said Anna. These are the three biggest challenges for innovators in large organizations and the three biggest enablers of success. and Ian F Smith, Director one-time use only and expires after 24 hours. The oldest executive at Wave Life Sciences Ltd. is KojiMiura, 71, who is the Independent Director. Prevnar, a shot that prevents pneumococcal infections, is a Pfizer blockbuster. In support of his arguments, he shared insights from government and industry professionals and cited facts and figures on the trajectory of the drug market. What an undertaking! The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Past performance is a poor indicator of future performance. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. $3.3K . Peter Kolchinsky - Insider Trading Tracker . He currently manages a fund that invests in healthcare and biotechnology companies. Anna and Peter originally hoped to find a vacation home that was big enough to share with friends and family and looked at the inn more out of curiosity than with any real intention to purchase it. Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. In total, Peter Kolchinsky has made about 2 transactions recently at Mineralys Therapeutics, Inc. The current estimated net worth of Mineralys Therapeutics, Inc's Director, Peter Kolchinsky, is estimated to be about $2.7B . It will take some time, but rest assured: a coronavirus vaccine is coming, and it will work. In this conversation. In the interim, they plan to invite local folks in to see the changes, try out some wines, and make new friends. Peter Kolchinsky: It has infected people in different parts of the world. Dr. Kolchinsky is a founder and Managing Partner of RA Capital Management, L.P., a multi-stage investment manager which is dedicated to evidence-based investing in healthcare and life science companies that are developing drugs, medical devices, and diagnostics, where he has worked since 2001. Sometimes Anna goes by various nicknames including Anna H Kolchinsky, Anna I Haas, Anna Haas Kolchinsky and Anna Haas Kolchinsky. , Keri said, adding that she hopes the new business still allows her some time for her own writing. Come and visit me at the Pacific Water Conference, booth 520! As of 23 June 2020 he still owns at least 9,011,651 units of Wave Life Sciences stock. Peter Kolchinsky's largest purchase order was 2,206,685 units , worth over He co-founded and runs the Boston-based investment firm RA Capital Management, writes and teaches about biomedical entrepreneurship and its potential to transform global health, serves on the boards of several public and private drug development companies, and has served on the Board of Global Science and Technology for the National . Lefkofsky co-founded Groupon, is a trustee of many marquee Chicago institutions and co-manages the Midwest VC firm Lightbank, which is currently looking to raise $250 million for its third fund, per another document filed with the SEC last November. On average, Peter trades about 366,737 units every 19 days since 2014. The campaign launched last year, targeting people in their 20s and 30s, Merz Aesthetics North America president Patrick Urban told Endpoints News at the time. Past performance is a poor indicator of future performance. After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA. But there was a new treatment he could try: a targeted radiotherapy called Pluvicto if he could get it in time. Kolchinsky's new book, The Great American Drug Deal: A New Prescription for Innovative and.